SIGA Technologies Inc
SIGA6.570USD
+0.110+1.70%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
469.37MMarktkapitalisierung
9.67KGV TTM
mehr Informationen über SIGA Technologies Inc Unternehmen
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks, vaccines and therapies for emerging infectious diseases, and health preparedness. The Company's lead product is TPOXX, also known as tecovirimat and ST-246, an orally administered and intravenous (IV) formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the United States maintains a supply of TPOXX under Project BioShield. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox. It uses third parties known as contract manufacturing organizations to procure commercial raw materials and supplies, and to manufacture TPOXX.
Unternehmensinformationen
BörsenkürzelSIGA
Name des UnternehmensSIGA Technologies Inc
IPO-datumSep 09, 1997
CEODr. Diem Nguyen, Ph.D.
Anzahl der mitarbeiter46
WertpapierartOrdinary Share
GeschäftsjahresendeSep 09
Addresse31 East 62Nd Street
StadtNEW YORK
BörseNASDAQ Global Market Consolidated
LandUnited States of America
Postleitzahl10065
Telefon12126729100
Websitehttps://www.siga.com/
BörsenkürzelSIGA
IPO-datumSep 09, 1997
CEODr. Diem Nguyen, Ph.D.
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel J. Luckshire
Mr. Daniel J. Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Chief Financial Officer, Executive Vice President, Corporate Secretary
275.06K
+4.50%
Dr. Dennis E. Hruby, Ph.D.
Dr. Dennis E. Hruby, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
191.05K
+12.87%
Mr. Jaymie A. Durnan
Mr. Jaymie A. Durnan
Independent Director
Independent Director
71.87K
+22.83%
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
67.65K
--
Mr. Julian Nemirovsky
Mr. Julian Nemirovsky
Independent Director
Independent Director
56.87K
+30.70%
Gen. (Retd.) John M. (Jack) Keane
Gen. (Retd.) John M. (Jack) Keane
Independent Director
Independent Director
--
--
Suzanne Harnett
Suzanne Harnett
Senior Vice President - Corporate Affairs and Investor Relations
Senior Vice President - Corporate Affairs and Investor Relations
--
--
Mr. Lawrence R. (Larry) Miller
Mr. Lawrence R. (Larry) Miller
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Harold E. Ford, Jr.
Mr. Harold E. Ford, Jr.
Independent Director
Independent Director
--
--
Mr. Joseph W. (Chip) Marshall, III
Mr. Joseph W. (Chip) Marshall, III
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel J. Luckshire
Mr. Daniel J. Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Chief Financial Officer, Executive Vice President, Corporate Secretary
275.06K
+4.50%
Dr. Dennis E. Hruby, Ph.D.
Dr. Dennis E. Hruby, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
191.05K
+12.87%
Mr. Jaymie A. Durnan
Mr. Jaymie A. Durnan
Independent Director
Independent Director
71.87K
+22.83%
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
67.65K
--
Mr. Julian Nemirovsky
Mr. Julian Nemirovsky
Independent Director
Independent Director
56.87K
+30.70%
Gen. (Retd.) John M. (Jack) Keane
Gen. (Retd.) John M. (Jack) Keane
Independent Director
Independent Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
Canada
5.82M
82.68%
United States
1.22M
17.32%
Europe, Middle East and Africa (EMEA)
0.00
0.00%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Wed, Jul 23
Aktualisiert: Wed, Jul 23
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
MacAndrews & Forbes Holdings, Inc.
33.81%
Lewis (John Latane IV)
7.38%
Hotchkis and Wiley Capital Management, LLC
4.42%
BlackRock Institutional Trust Company, N.A.
4.41%
The Vanguard Group, Inc.
3.48%
Other
46.50%
Aktionäre
Aktionäre
Anteil
MacAndrews & Forbes Holdings, Inc.
33.81%
Lewis (John Latane IV)
7.38%
Hotchkis and Wiley Capital Management, LLC
4.42%
BlackRock Institutional Trust Company, N.A.
4.41%
The Vanguard Group, Inc.
3.48%
Other
46.50%
Aktionärstypen
Aktionäre
Anteil
Holding Company
33.81%
Investment Advisor
24.00%
Investment Advisor/Hedge Fund
21.61%
Individual Investor
9.60%
Hedge Fund
3.45%
Pension Fund
1.43%
Research Firm
0.90%
Bank and Trust
0.22%
Insurance Company
0.02%
Other
4.96%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
370
67.87M
95.00%
-3.71M
2025Q1
373
68.25M
95.72%
+20.84M
2024Q4
383
67.66M
94.75%
+19.97M
2024Q3
383
69.27M
97.02%
+23.98M
2024Q2
372
66.53M
93.22%
+21.86M
2024Q1
353
41.88M
58.83%
-3.74M
2023Q4
341
41.95M
58.96%
-4.28M
2023Q3
343
42.34M
59.51%
-1.31M
2023Q2
346
70.75M
97.35%
-304.51K
2023Q1
349
70.50M
96.45%
-1.04M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
MacAndrews & Forbes Holdings, Inc.
24.16M
33.81%
--
--
Apr 17, 2025
Lewis (John Latane IV)
5.27M
7.38%
--
--
Apr 17, 2025
Hotchkis and Wiley Capital Management, LLC
3.16M
4.42%
+1.09M
+52.93%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.15M
4.41%
-66.70K
-2.07%
Mar 31, 2025
The Vanguard Group, Inc.
2.48M
3.48%
+10.82K
+0.44%
Mar 31, 2025
AltraVue Capital, LLC.
2.40M
3.36%
-242.57K
-9.19%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.35M
3.29%
+226.82K
+10.67%
Mar 31, 2025
First Wilshire Securities Management, Inc.
1.59M
2.22%
-787.49K
-33.17%
Mar 31, 2025
American Century Investment Management, Inc.
1.37M
1.92%
+98.69K
+7.76%
Mar 31, 2025
Citadel Advisors LLC
1.16M
1.62%
+108.91K
+10.35%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
Cambria Micro and SmallCap Shareholder Yield ETF
1.07%
Acquirers Small and Micro Deep Value ETF
1.04%
Lattice Hartford Multifactor Small Cap ETF
0.61%
Invesco NASDAQ Future Gen 200 ETF
0.49%
First Trust Dow Jones Select MicroCap Index Fund
0.45%
Royce Quant Small-Cap Quality Value ETF
0.4%
First Trust Active Factor Small Cap ETF
0.35%
Vanguard US Multifactor ETF
0.14%
WisdomTree US SmallCap Fund
0.13%
VictoryShares Small Cap Free Cash Flow ETF
0.13%
Mehr Anzeigen
Cambria Micro and SmallCap Shareholder Yield ETF
Anteil1.07%
Acquirers Small and Micro Deep Value ETF
Anteil1.04%
Lattice Hartford Multifactor Small Cap ETF
Anteil0.61%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.49%
First Trust Dow Jones Select MicroCap Index Fund
Anteil0.45%
Royce Quant Small-Cap Quality Value ETF
Anteil0.4%
First Trust Active Factor Small Cap ETF
Anteil0.35%
Vanguard US Multifactor ETF
Anteil0.14%
WisdomTree US SmallCap Fund
Anteil0.13%
VictoryShares Small Cap Free Cash Flow ETF
Anteil0.13%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
